Cargando…
Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics
The repositioning or “repurposing” of existing therapies for alternative disease indications is an attractive approach that can save significant investments of time and money during drug development. For cancer indications, the primary goal of repurposed therapies is on efficacy, with less restricti...
Autores principales: | Hernandez, J. Javier, Pryszlak, Michael, Smith, Lindsay, Yanchus, Connor, Kurji, Naheed, Shahani, Vijay M., Molinski, Steven V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694537/ https://www.ncbi.nlm.nih.gov/pubmed/29184849 http://dx.doi.org/10.3389/fonc.2017.00273 |
Ejemplares similares
-
DRUG REPURPOSING—Overcoming the translational hurdles to clinical use
por: Martin, Jennifer H., et al.
Publicado: (2019) -
Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
por: Abdulaziz, Leena, et al.
Publicado: (2022) -
Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016) -
Repurposing Approved Drugs as Fluoroquinolone Potentiators to Overcome Efflux Pump Resistance in Staphylococcus aureus
por: Mahey, Nisha, et al.
Publicado: (2021) -
Give chance a chance
por: Nachury, Maxence V.
Publicado: (2011)